Observational studyCancer research communications2026
Melanoma Recurrence Prediction Using a Tissue-Free Epigenomic Molecular Residual Disease Assay: A Multicenter Prospective Observational Study (COSMOS-MEL01).
Kenjiro Namikawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.